Effects of combined anisodamine and neostigmine treatment on the inflammatory response and liver regeneration of obstructive jaundice rats after hepatectomy

Biomed Res Int. 2014:2014:362024. doi: 10.1155/2014/362024. Epub 2014 Nov 12.

Abstract

Background: Cholestasis is associated with high rates of morbidity and mortality in patients undergoing major liver resection. This study aimed to evaluate the effects of a combined anisodamine and neostigmine (Ani+Neo) treatment on the inflammatory response and liver regeneration in rats with obstructive jaundice (OJ) after partial hepatectomy.

Materials and methods: OJ was induced in the rats by bile duct ligation. After 7 days biliary drainage and partial hepatectomy were performed. These rats were assigned to a saline group or an Ani+Neo treatment group. The expressions of inflammatory mediators, liver regeneration, and liver damage were assessed at 48 h after hepatectomy.

Results: The mRNA levels of TNF-α, IL-1β, IL-6, MCP-1, and MIP-1α, in the remnant livers, and the serum levels of TNF-α and IL-1β were substantially reduced in the Ani+Neo group compared with saline group (P<0.05). The Ani+Neo treatment obviously promoted liver regeneration as indicated by the liver weights and Ki-67 labeling index (P<0.05). The serum albumin and γ-GT levels and liver neutrophil infiltration also significantly improved in the Ani+Neo group (P<0.05) compared with the saline group.

Conclusions: These results demonstrate that the combined anisodamine and neostigmine treatment is able to improve the liver regeneration in rats with OJ by substantially alleviating the inflammatory response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drug Combinations
  • Hepatectomy / adverse effects
  • Humans
  • Inflammation / blood
  • Inflammation / drug therapy*
  • Inflammation / pathology
  • Interleukin-6 / blood
  • Jaundice, Obstructive / blood
  • Jaundice, Obstructive / drug therapy*
  • Jaundice, Obstructive / pathology
  • Liver Regeneration / drug effects*
  • Neostigmine / administration & dosage
  • Rats
  • Solanaceous Alkaloids / administration & dosage
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Drug Combinations
  • Interleukin-6
  • Solanaceous Alkaloids
  • Tumor Necrosis Factor-alpha
  • anisodamine
  • Neostigmine